The management of eosinophilic esophagitis

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 4, 2013, Pages 332-340

  Greenhawt, Matthew ^a   Aceves, Seema S ^b   Spergel, Jonathan M ^c   Rothenberg, Marc E ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

APT; Atopy patch testing; Dietary management; EGD; Elemental diet; Elimination diet; Empiric diet; EoE; Eosinophil; Eosinophilic esophagitis; FP; GERD; GI; HPF; Ig; NLR; NPV; OCS; OVB; PLR; PPI; PPIRee; PPV; PST; QoL; SFED; Six food elimination diet; Skin testing; Swallowed steroid therapy; Targeted elimination diet; TCS; TGF; TIGERS

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FOOD ALLERGEN; PROTON PUMP INHIBITOR;

ARTICLE; ATOPY PATCH TEST; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIET RESTRICTION; DIET THERAPY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ELEMENTAL DIET THERAPY; EMPIRIC DIETARY ELIMINATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; FAMILY HISTORY; GASTROESOPHAGEAL REFLUX; HUMAN; IMMUNE FUNCTION TEST; MEDICAL SPECIALIST; NONHUMAN; PATIENT MONITORING; PREDICTIVE VALUE; PRICK SKIN TEST; SENSITIVITY AND SPECIFICITY; SYMPTOM; TARGETED DIETARY ELIMINATION; UNSPECIFIED SIDE EFFECT;

ATOPY PATCH TESTING; DIETARY MANAGEMENT; ELEMENTAL DIET; ELIMINATION DIET; EMPIRIC DIET; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; SIX-FOOD ELIMINATION DIET; SKIN TESTING; SWALLOWED STEROID THERAPY; TARGETED ELIMINATION DIET;

ADRENAL CORTEX HORMONES; ALGORITHMS; ANIMALS; DIET; DISEASE PROGRESSION; EOSINOPHILIC ESOPHAGITIS; HUMANS;

EID: 84879813464     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.05.009     Document Type: Article

References (69)

1. Liacouras C.A., Furuta G.T., Hirano I., Atkins D., Attwood S.E., Bonis P.A., et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. JAllergy Clin Immunol 2011, 128:3-20.e6. quiz 1-2.
2. Straumann A., Aceves S.S., Blanchard C., Collins M.H., Furuta G.T., Hirano I., et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012, 67:477-490.
3. Furuta G.T., Liacouras C.A., Collins M.H., Gupta S.K., Justinich C., Putnam P.E., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363.
4. Dobbins J.W., Sheahan D.G., Behar J. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology 1977, 72:1312-1316.
5. DeBrosse C.W., Collins M.H., Buckmeier Butz B.K., Allen C.L., King E.C., Assa'ad A.H., et al. Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. JAllergy Clin Immunol 2010, 126:112-119.
6. Rothenberg M.E. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009, 137:1238-1249.
7. Hruz P., Straumann A., Bussmann C., Heer P., Simon H.U., Zwahlen M., et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County. Switzerland. J Allergy Clin Immunol 2011, 128:1349-1350.e5.
8. van Rhijn B.D., Verheij J., Smout A.J., Bredenoord A.J. Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil 2013, 25:47-52.e5.
9. Soon I.S., Butzner J.D., Kaplan G.G., Debruyn J.C. Incidence and prevalence of eosinophilic esophagitis in children: systematic review and meta-analysis. JPediatr Gastroenterol Nutr 2013 March 26, [Epub ahead of print].
10. Rothenberg M.E., Spergel J.M., Sherrill J.D., Annaiah K., Martin L.J., Cianferoni A., et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010, 42:289-291.
11. Spergel J.M. New genetic links in eosinophilic esophagitis. Genome Med 2010, 2:60.
12. Blanchard C., Stucke E.M., Burwinkel K., Caldwell J.M., Collins M.H., Ahrens A., et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. JImmunol 2010, 184:4033-4041.
13. Sayej W.N., Patel R., Baker R.D., Tron E., Baker S.S. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. JPediatr Gastroenterol Nutr 2009, 49:393-399.
14. Ngo P., Furuta G.T., Antonioli D.A., Fox V.L. Eosinophils in the esophagus: peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666-1670.
15. Molina-Infante J., Ferrando-Lamana L., Fernandez-Bermejo M., Porcel-Carreno S. Eosinophilic esophagitis in GERD patients: a clinicopathological diagnosis using proton pump inhibitors. Am J Gastroenterol 2009, 104:2856-2857.
16. Lucendo A.J., Navarro M., Comas C., Pascual J.M., Burgos E., Santamaria L., et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 2007, 31:598-606.
17. Dellon E.S., Gibbs W.B., Fritchie K.J., Rubinas T.C., Wilson L.A., Woosley J.T., et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009, 7:1305-1313. quiz 261.
18. Aceves S.S., Newbury R.O., Dohil M.A., Bastian J.F., Dohil R. Asymptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009, 103:401-406.
19. Pentiuk S., Putnam P.E., Collins M.H., Rothenberg M.E. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. JPediatr Gastroenterol Nutr 2009, 48:152-160.
20. Prasad G.A., Talley N.J., Romero Y., Arora A.S., Kryzer L.A., Smyrk T.C., et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007, 102:2627-2632.
21. Matsukura M., Yamada H., Yudate T., Tezuka T., Chihara J. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients. JClin Lab Immunol 1996, 48:109-122.
22. Adachi T., Motojima S., Hirata A., Fukuda T., Kihara N., Kosaku A., et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. JAllergy Clin Immunol 1996, 98:S207-S215.
23. Debierre-Grockiego F., Leduc I., Prin L., Gouilleux-Gruart V. Dexamethasone inhibits apoptosis of eosinophils isolated from hypereosinophilic patients. Immunobiology 2001, 204:517-523.
24. Mygind N., Nielsen L.P., Hoffmann H.J., Shukla A., Blumberga G., Dahl R., et al. Mode of action of intranasal corticosteroids. JAllergy Clin Immunol 2001, 108:S16-S25.
25. Das A.M., Flower R.J., Hellewell P.G., Teixeira M.M., Perretti M. Anovel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br J Pharmacol 1997, 121:97-104.
26. Liacouras C.A., Wenner W.J., Brown K., Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. JPediatr Gastroenterol Nutr 1998, 26:380-385.
27. Vitellas K.M., Bennett W.F., Bova J.G., Johnson J.C., Greenson J.K., Caldwell J.H. Radiographic manifestations of eosinophilic gastroenteritis. Abdom Imaging 1995, 20:406-413.
28. Caldwell J.M., Blanchard C., Collins M.H., Putnam P.E., Kaul A., Aceves S.S., et al. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. JAllergy Clin Immunol 2010, 125:879-888.e8.
29. Faubion W.A., Perrault J., Burgart L.J., Zein N.N., Clawson M., Freese D.K. Treatment of eosinophilic esophagitis with inhaled corticosteroids. JPediatr Gastroenterol Nutr 1998, 27:90-93.
30. Noel R.J., Putnam P.E., Collins M.H., Assa'ad A.H., Guajardo J.R., Jameson S.C., et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568-575.
31. Konikoff M.R., Noel R.J., Blanchard C., Kirby C., Jameson S.C., Buckmeier B.K., et al. Arandomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131:1381-1391.
32. Aceves S.S., Dohil R., Newbury R.O., Bastian J.F. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. JAllergy Clin Immunol 2005, 116:705-706.
33. Aceves S.S., Bastian J.F., Newbury R.O., Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007, 102:2271-2279. quiz 80.
34. Aceves S.S., Chen D., Newbury R.O., Dohil R., Bastian J.F., Broide D.H. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. JAllergy Clin Immunol 2010, 126:1198-1204.e4.
35. Aceves S.S., Newbury R.O., Chen D., Mueller J., Dohil R., Hoffman H., et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010, 65:109-116.
36. Dohil R., Newbury R., Fox L., Bastian J., Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010, 139:418-429.
37. Straumann A., Conus S., Degen L., Felder S., Kummer M., Engel H., et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010, 139:1526-1537.e1.
38. Straumann A., Conus S., Degen L., Frei C., Bussmann C., Beglinger C., et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011, 9:400-409.e1.
39. Helou E.F., Simonson J., Arora A.S. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol 2008, 103:2194-2199.
40. Hirano I. Editorial: Should patients with suspected eosinophilic esophagitis undergo a therapeutic trial of proton pump inhibition?. Am J Gastroenterol 2013, 108:373-375.
41. Molina-Infante J., Ferrando-Lamana L., Ripoll C., Hernandez-Alonso M., Mateos J.M., Fernandez-Bermejo M., et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011, 9:110-117.
42. Molina-Infante J., Zamorano J. Distinguishing eosinophilic esophagitis from gastroesophageal reflux disease upon PPI refractoriness: what about PPI-responsive esophageal eosinophilia?. Digestion 2012, 85:210.
43. Schroeder S., Capocelli K.E., Masterson J.C., Harris R., Protheroe C., Lee J.J., et al. Effect of proton pump inhibitor on esophageal eosinophilia. JPediatr Gastroenterol Nutr 2013, 56:166-172.
44. Zhang X., Cheng E., Huo X., Yu C., Zhang Q., Pham T.H., et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE 2012, 7:e50037.
45. Kottyan L.C., Collier A.R., Cao K.H., Niese K.A., Hedgebeth M., Radu C.G., et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 2009, 114:2774-2782.
46. Kelly K.J., Lazenby A.J., Rowe P.C., Yardley J.H., Perman J.A., Sampson H.A. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
47. Markowitz J.E., Spergel J.M., Ruchelli E., Liacouras C.A. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003, 98:777-782.
48. Liacouras C.A., Spergel J.M., Ruchelli E., Verma R., Mascarenhas M., Semeao E., et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198-1206.
49. Peterson K.A., Byrne K.R., Vinson L.A., Ying J., Boynton K.K., Fang J.C., et al. Elemental Diet Induces Histologic Response in Adult Eosinophilic Esophagitis. Am J Gastroenterol 2013, 108:759-766.
50. Pedrosa M., Pascual C.Y., Larco J.I., Esteban M.M. Palatability of hydrolysates and Other substitution formulas for cow's milk-allergic children: a comparative study of taste, smell, and texture evaluated by healthy volunteers. JInvestig Allergol Clin Immunol 2006, 16:351-356.
51. Spergel J.M., Beausoleil J.L., Mascarenhas M., Liacouras C.A. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. JAllergy Clin Immunol 2002, 109:363-368.
52. Spergel J.M., Andrews T., Brown-Whitehorn T.F., Beausoleil J.L., Liacouras C.A. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005, 95:336-343.
53. Spergel J.M., Brown-Whitehorn T., Beausoleil J.L., Shuker M., Liacouras C.A. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. JAllergy Clin Immunol 2007, 119:509-511.
54. Molina-Infante J., Martin-Noguerol E., Alvarado-Arenas M., Porcel-Carreno S.L., Jimenez-Timon S., Hernandez-Arbeiza F.J. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. JAllergy Clin Immunol 2012, 130:1200-1202.
55. Henderson C.J., Abonia J.P., King E.C., Putnam P.E., Collins M.H., Franciosi J.P., et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. JAllergy Clin Immunol 2012, 129:1570-1578.
56. Spergel J.M., Brown-Whitehorn T.F., Cianferoni A., Shuker M., Wang M.-L., Verma R., et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. JAllergy Clin Immunol 2012, 130:461-467.
57. Kagalwalla A.F., Sentongo T.A., Ritz S., Hess T., Nelson S.P., Emerick K.M., et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1097-1102.
58. Kagalwalla A.F., Shah A., Li B.U., Sentongo T.A., Ritz S., Manuel-Rubio M., et al. Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. JPediatr Gastroenterol Nutr 2011, 53:145-149.
59. Gonsalves N., Yang G.Ä., Doerfler B., Ritz S., Ditto A.M., Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012, 142:1451-1459.e1.
60. Lucendo A.J., Arias A., Molina-Infante J., Rodriguez-Sanchez J., Rodrigo L., Nantes O., et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. JAllergy Clin Immunol 2013, 131:797-804.
61. Straumann A. The natural history and complications of eosinophilic esophagitis. Thorac Surg Clin 2011, 21:575-587.
62. Spergel J.M., Brown-Whitehorn T.F., Beausoleil J.L., Franciosi J., Shuker M., Verma R., et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. JPediatr Gastroenterol Nutr 2009, 48:30-36.
63. Lucendo A.J., Arias A., De Rezende L.C., Yague-Compadre J.L., Mota-Huertas T., Gonzalez-Castillo S., et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. JAllergy Clin Immunol 2011, 128:1037-1046.
64. Aceves S.S. Tissue remodeling in patients with eosinophilic esophagitis: what lies beneath the surface?. JAllergy Clin Immunol 2011, 128:1047-1049.
65. Franciosi J.P., Hommel K.A., Bendo C.B., King E.C., Collins M.H., Eby M.D., et al. PedsQL Eosinophilic Esophagitis Module: Feasibility, Reliability and Validity. JPediatr Gastroenterol Nutr 2013 March 8, [Epub ahead of print].
66. Franciosi J.P., Hommel K.A., DeBrosse C.W., Greenberg A.B., Greenler A.J., Abonia J.P., et al. Quality of life in paediatric eosinophilic oesophagitis: what is important to patients?. Child Care Health Dev 2012, 38:477-483.
67. Klinnert M.D. Psychological impact of eosinophilic esophagitis on children and families. Immunol Allergy Clin North Am 2009, 29:99-107. x.
68. Franciosi J.P., Hommel K.A., Greenberg A.B., Debrosse C.W., Greenler A.J., Abonia J.P., et al. Development of the pediatric quality of life inventory eosinophilic esophagitis module items: qualitative methods. BMC Gastroenterol 2012, 12:135.
69. Abonia JP, Wen T, Stucke EM, Grotjan T, Griffith MS, Kemme KA, etal. High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol. 2013 April 19 [Epub ahead of print].